On July 29, 2026, Florida’s Second District Court of Appeal reversed a lower-court judgment for Hillsborough County firefighter-paramedic Angelo Giambrone. HR Dive reported the decision on July 31.

The employee had tested positive after a random urine screen. The trial court found no evidence of on-duty use, possession, performance problems, or suspected impairment, but the appellate court concluded that the governing agreement and Florida law did not require the county to treat his medical marijuana authorization as a protected prescription or accommodation.

A Florida medical marijuana card does not by itself guarantee protection from workplace testing or discipline. Read the employer’s written policy and any labor agreement before assuming that lawful off-duty use is protected.

Do not work, drive, or perform safety-sensitive tasks while impaired. If a test or accommodation issue arises, preserve the relevant policy, testing notice, medication list, and clinical records, then seek qualified employment advice.

Document the clinical indication, product, route, dose, timing, observed benefit, adverse effects, and functional risks. Explain that state authorization and workplace accommodation are distinct questions.

Avoid describing medical cannabis as a conventional prescription when the legal distinction matters. In Florida, the court emphasized that cannabis is authorized through physician certification and dispensed through licensed treatment centers, not through the pharmacist prescription system incorporated into this labor agreement.

Medical cannabis laws often protect patients from state criminal penalties without creating uniform employment rights. Workplace outcomes can depend on the jurisdiction, job duties, test method, federal obligations, employer policy, and negotiated contract language.

The case also shows why detection and impairment should be discussed separately. The record described a positive urine result without evidence of on-duty impairment, yet the labor agreement itself defined a confirmed positive test as impairment for employment purposes.

The opinion does not hold that every Florida employer must discipline a medical cannabis patient, or that every policy permits discipline based solely on off-duty use. The court expressly said that different employers, labor agreements, and policies were not before it.

It does not establish that the employee was clinically impaired at work, that urine testing precisely measures current impairment, or that the same result would follow outside Florida.

Urine cannabinoid testing generally documents exposure, not a precise time of use or a direct level of current functional impairment. Detection varies with product, dose, route, frequency, specimen, and individual factors.

Cannabis can still affect attention, reaction time, coordination, judgment, and sedation. Risks may increase with alcohol, sedating medications, high-THC products, unfamiliar formulations, or safety-sensitive work.

Headlines may overstate the ruling as a statewide license for every employer to penalize every off-duty patient. The majority repeatedly tied its reasoning to the county’s policy, the firefighter labor agreement, and Florida’s statutory framework.

The 40-page opinion also contains separate concurrences. One judge agreed only in the result and cautioned that the majority went beyond what was necessary; another agreed with judgment for the county but supplied additional analysis of the employee’s civil-rights claims.

The decision leaves employment protection largely dependent on legislative text, negotiated agreements, and employer policy. Patients benefit when rules clearly distinguish off-duty exposure, current impairment, safety-sensitive duties, and consequences before testing occurs.

Labor groups and employers can address those distinctions directly in collective bargaining and written policies. Courts interpret the text in front of them; they do not automatically create a broader accommodation rule.

Medical cannabis authorization can reduce state criminal exposure without guaranteeing protection under employment, disability, labor, licensing, or federal law.

Clinicians can help patients understand health and functional risks. They cannot determine the legal effect of a workplace policy or collective bargaining agreement.

The medically important distinction is simple: evidence of prior cannabis exposure is not automatically evidence of present impairment. The legally important distinction is equally important: a state medical marijuana card is not automatically a workplace accommodation.

Patients in safety-sensitive roles should discuss timing, product effects, interactions, and functional risk with their clinician, then review the actual employment rules with an appropriate legal or labor professional before assuming protection.

Four questions that matter